KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Revenue (2016 - 2025)

Chemed (CHE) has 17 years of Revenue data on record, last reported at $639.3 million in Q4 2025.

  • For Q4 2025, Revenue changed 0.1% year-over-year to $639.3 million; the TTM value through Dec 2025 reached $2.5 billion, up 4.06%, while the annual FY2025 figure was $2.5 billion, 4.06% up from the prior year.
  • Revenue reached $639.3 million in Q4 2025 per CHE's latest filing, up from $624.9 million in the prior quarter.
  • Across five years, Revenue topped out at $646.9 million in Q1 2025 and bottomed at $526.5 million in Q3 2022.
  • Average Revenue over 5 years is $575.0 million, with a median of $562.3 million recorded in 2023.
  • Peak YoY movement for Revenue: soared 3506.52% in 2021, then decreased 2.26% in 2022.
  • A 5-year view of Revenue shows it stood at $541.0 million in 2021, then rose by 1.05% to $546.7 million in 2022, then rose by 7.18% to $585.9 million in 2023, then increased by 9.23% to $640.0 million in 2024, then decreased by 0.1% to $639.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $639.3 million in Q4 2025, $624.9 million in Q3 2025, and $618.8 million in Q2 2025.